Synonym
PRT4165; PRT-4165; PRT 4165.
IUPAC/Chemical Name
2-(3-Pyridinylmethylene)-1H-Indene-1,3(2H)-dione
InChi Key
OMHZFEWYVFWVLI-UHFFFAOYSA-N
InChi Code
InChI=1S/C15H9NO2/c17-14-11-5-1-2-6-12(11)15(18)13(14)8-10-4-3-7-16-9-10/h1-9H
SMILES Code
O=C1/C(C(C2=C1C=CC=C2)=O)=C\C3=CC=CN=C3
Appearance
Yellow solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
|
Solvent |
mg/mL |
mM |
| Solubility |
| DMSO |
20.0 |
85.00 |
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.
Preparing Stock Solutions
The following data is based on the
product
molecular weight
235.24
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Ni S, Takada Y, Ando T, Yu S, Yamashita Y, Takahashi Y, Sawada M, Oba M, Itoh Y, Suzuki T. Identification of a novel histone H2A mono-ubiquitination- inhibiting cell-active small molecule. Bioorg Med Chem Lett. 2024 Jun 1;105:129759. doi: 10.1016/j.bmcl.2024.129759. Epub 2024 Apr 16. PMID: 38636717.
2: Szustka A, Kozal K, Krześlak A. RING1 Inhibition Has a Cell-Specific Antitumoral Role by Promoting Autophagy in Endometrial Cancer Cells. Cell Physiol Biochem. 2024 Jan 8;58(1):1-13. doi: 10.33594/000000679. PMID: 38219048.
3: Shi P, Wu J, Li M, Cao Y, Wu J, Ren P, Liu K, Zhou J, Sha Y, Zhang Q, Sun H. Upregulation of Hsp27 via further inhibition of histone H2A ubiquitination confers protection against myocardial ischemia/reperfusion injury by promoting glycolysis and enhancing mitochondrial function. Cell Death Discov. 2023 Dec 19;9(1):466. doi: 10.1038/s41420-023-01762-x. PMID: 38114486; PMCID: PMC10730859.
4: Müller MR, Burmeister A, Skowron MA, Stephan A, Bremmer F, Wakileh GA, Petzsch P, Köhrer K, Albers P, Nettersheim D. Therapeutical interference with the epigenetic landscape of germ cell tumors: a comparative drug study and new mechanistical insights. Clin Epigenetics. 2022 Jan 7;14(1):5. doi: 10.1186/s13148-021-01223-1. PMID: 34996497; PMCID: PMC8742467.
5: Desai D, Khanna A, Pethe P. Inhibition of RING1B alters lineage specificity in human embryonic stem cells. Cell Biol Int. 2020 Jun;44(6):1299-1311. doi: 10.1002/cbin.11325. Epub 2020 Mar 2. PMID: 32068319.
6: Ohtaka M, Itoh M, Tohda S. BMI1 Inhibitors Down-regulate NOTCH Signaling and Suppress Proliferation of Acute Leukemia Cells. Anticancer Res. 2017 Nov;37(11):6047-6053. doi: 10.21873/anticanres.12052. PMID: 29061784.
7: Ismail IH, McDonald D, Strickfaden H, Xu Z, Hendzel MJ. A small molecule inhibitor of polycomb repressive complex 1 inhibits ubiquitin signaling at DNA double-strand breaks. J Biol Chem. 2013 Sep 13;288(37):26944-54. doi: 10.1074/jbc.M113.461699. Epub 2013 Jul 30. PMID: 23902761; PMCID: PMC3772243.
